"Predicting Eli Lilly's Path to a $1 Trillion Market Cap"

Eli Lilly's recent success is attributed to its work in the weight-loss market, particularly with the approval of tirzepatide for treating type 2 diabetes and obesity. Analysts predict rapid growth in this market, with estimates of tirzepatide becoming one of the best-selling medicines in the industry. Additionally, the company has made progress in other areas, such as potential Alzheimer's disease therapy and other regulatory nods. With a strong pipeline and underlying business, Eli Lilly is expected to reach a trillion-dollar market capitalization in the next five years, making it a worthwhile investment for the future.